Browsing by Author Bonnet, Fabrice
Showing results 1 to 4 of 4
Issue Date | Title | Author(s) |
Apr-2023 | HbA1c trajectories over 3 years in people with type 2 diabetes starting second-line glucose-lowering therapy: The prospective global DISCOVER study | Bongaerts, Brenda; Kuss, Oliver; Bonnet, Fabrice; Chen, Hungta; Cooper, Andrew; Fenici, Peter; Gomes, Marilia B.; Hammar, Niklas; Ji, Linong; Khunti, Kamlesh; Medina, Jesus; Nicolucci, Antonio; Shestakova, Marina V.; Watada, Hirotaka; Rathmann, Wolfgang |
2017 | Towards an improved global understanding of treatment and outcomes in people with type 2 diabetes: Rationale and methods of the DISCOVER observational study program | Ji, Linong; Bonnet, Fabrice; Charbonnel, Bernard; Gomes, Marilia B.; Kosiborod, Mikhail; Khunti, Kamlesh; Nicolucci, Antonio; Pocock, Stuart; Rathmann, Wolfgang; Shestakova, Marina V.; Shimomura, Iichiro; Watada, Hirotaka; Fenici, Peter; Hammar, Niklas; Hashigami, Kiyoshi; Macaraeg, Greg; Surmont, Filip; Medina, Jesus |
Apr-2021 | Type 2 diabetes and heart failure: insights from the global DISCOVER study | Arnold, Suzanne, V; Khunti, Kamlesh; Bonnet, Fabrice; Charbonnel, Bernard; Chen, Hungta; Cid-Ruzafa, Javier; Cooper, Andrew; Fenici, Peter; Gomes, Marilia B.; Hammar, Niklas; Ji, Linong; Luporini-Saraiva, Gabriela; Medina, Jesus; Nicolucci, Antonio; Ramirez, Larisa; Shestakova, Marina, V; Shimomura, Iichiro; Surmont, Filip; Tang, Fengming; Vora, Jiten; Watada, Hirotaka; Kosiborod, Mikhail |
Aug-2021 | What are the factors associated with long-term glycaemic control in patients with type 2 diabetes and elevated glycated haemoglobin (>= 7.0%) at initiation of second-line therapy? Results from the DISCOVER study | Bonnet, Fabrice; Chen, Hungta; Cooper, Andrew; Gomes, Marilia B.; Ji, Linong; Leigh, Paul; Ramirez, Larisa; Shestakova, Marina, V; Shimomura, Iichiro; Siddiqui, Afrah; Tang, Fengming; Vora, Jiten; Watada, Hirotaka; Khunti, Kamlesh |